Wall Street's main averages closed in the red on Friday, taking home weekly losses—and on track to end the month down—as investors continued to assess the latest company earnings and technology stocks ...

If you are wondering whether Thermo Fisher Scientific's current share price lines up with its underlying worth, you are not alone. This article walks through that question step by step. The stock last ...

The Global Latex Agglutination Test Kits Market offers significant opportunities due to the rising prevalence of infectious diseases and demand for rapid, cost-effective diagnostics, especially in ...

Novel psychoactive substances (NPS) are chemically engineered substances designed to mimic the effects of traditional controlled drugs such as opioids, stimulants, and cannabinoids. These compounds ...

Discover how PGNAA is transforming materials analysis in mining, cement, and steel. Get expert insights from Thermo Fisher’s Garry Noble.

Thermo Fisher Scientific: recent gains put performance in focus Thermo Fisher Scientific (TMO) has drawn investor attention ...

The growth of the Poria Cocos Extract Market is driven by rising demand for natural and plant-based ingredients across pharmaceuticals, ...

Despite the jump in share price, some analysts remain skeptical about the likelihood of a transaction successfully crossing ...

Discover how modern Listeria monitoring solutions can support faster, more reliable food and environmental testing, and help elevate your laboratory’s efficiency and confidence in results.

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will present at the J.P. Morgan 2026 ...

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors has authorized the repurchase of $5 billion of shares of its common stock in ...

Thermo Fisher Scientific is breaking out the big bills to score a clinical research treat. With $8.875 billion in cash, the life science giant is adding Clario Holdings to its goodie bag, the company ...